
Duruvasan Ramachandra
About Duruvasan Ramachandra
Data last updated:
Duruvasan Ramachandra is a Director at Shriram Capital Private Limited (since 2023), Director at Sapigen Biologix Private Limited (since 2025) and Director at Shriram Life Insurance Company Limited (since 2019). The companies operate in Financial Services, Research & Development and Information Technology. The 2 current companies with reported revenue have a combined latest revenue of ₹6,063 Cr; the largest is Shriram Capital Private Limited at ₹6,059 Cr (FY 2020). Earlier, Duruvasan Ramachandra was a Director at Ces Limited (2006–2024) and Director at Shriram Chits Tamilnadu Private Limited (2002–2007) and 7 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 Feb 2023 | 2011 | ₹6,059 Cr (FY 2020) | Active | |
| Director | 28 Mar 2025 | 2020 | ₹3.53 Cr (FY 2025) | Active | |
| Director | 17 May 2019 | 2005 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 29 Sep 2006 | 1985 | ₹525 Cr (FY 2025) | Active | |
| Director | 30 Mar 2002 | 1989 | ₹105 Cr (FY 2020) | Amalgamated | |
| Director | 25 Aug 2001 | 2000 | Active | ||
| Additional Director | 19 Oct 2015 | 2010 | ₹1,430 Cr (FY 2024) | Active | |
| Director | 01 Apr 2002 | 1987 | ₹89.92 Cr (FY 2024) | Active | |
| Director | 29 Mar 1996 | 1995 | Strike Off | ||
| Director | 29 Jun 1996 | 1981 | ₹191 Cr (FY 2020) | Amalgamated | |
| Director | 06 Jun 2012 | 1986 | ₹41,859 Cr (FY 2025) | Amalgamated | |
| Whole-Time Director | 18 Nov 2019 | 1974 | ₹7,932 Cr (FY 2022) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Duruvasan Ramachandra
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Duruvasan Ramachandra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Duruvasan Ramachandra
Duruvasan Ramachandra currently holds 3 directorships: Shriram Capital Private Limited (Director, since 17 Feb 2023, revenue ₹6,059 Cr (FY 2020)); Sapigen Biologix Private Limited (Director, since 28 Mar 2025, revenue ₹3.53 Cr (FY 2025)); Shriram Life Insurance Company Limited (Director, since 17 May 2019).
Duruvasan Ramachandra was first appointed on 29 Mar 1996 as Director at Kpr Investments P Ltd. The most recent appointment on record is 28 Mar 2025 at Sapigen Biologix Private Limited.
The 2 current companies of Duruvasan Ramachandra that report revenue have a combined latest revenue of ₹6,063 Cr: Shriram Capital Private Limited ₹6,059 Cr (FY 2020); Sapigen Biologix Private Limited ₹3.53 Cr (FY 2025).
Duruvasan Ramachandra held 9 earlier board appointments: Ces Limited (Director, 29 Sep 2006 to 29 Dec 2024); Shriram Chits Tamilnadu Private Limited (Director, 30 Mar 2002 to 29 Sep 2007); Prosperity Shop (India) Limited (Director, 25 Aug 2001 to 26 Dec 2007); Truhome Finance Limited (Additional Director, 19 Oct 2015 to 28 Jul 2016); Savery Transport Finance Limited (Director, 01 Apr 2002 to 09 Apr 2012); and 4 more.
The current boards of Duruvasan Ramachandra's companies include David Piers Dyson Marshall (Shriram Capital Private Limited), Jasmit Singh Gujral (Shriram Capital Private Limited), Kodumudi Pranatharthiharan Krishnan (Shriram Capital Private Limited), Lakshminarayanan (Shriram Capital Private Limited), Ravi Devaki Venkataraman (Shriram Capital Private Limited), Somasundaram Senthilnathan (Shriram Capital Private Limited), among others.